MOLECULAR EVIDENCE DEVELOPMENT
$343K
Revenue
4
Filings
Latest Financial Summary
| Fiscal Year | Revenue | Expenses | Net Assets | Contributions |
|---|---|---|---|---|
| FY 2018 | $343K | $865K | $0 | $251K |
Key Officers
J
JEFF ALLEN PHD
Chairman
R
RON COLLETTE CISSP
BOARD MEMBER
M
MARC SAMUELS JD
BOARD MEMBER
Filing History
Similar Organizations
Medical Research · ID
HEARTS FOR HADLEY
BOISE
LEWISTON CHAPTER 4
LEWISTON
